Biotechnology What’s Going On Neurology-Focused Axsome Therapeutics’ Stock On Monday? – Axsome Therapeutics (NASDAQ:AXSM) Read more
Biotechnology Neurology-Focused Axsome Therapeutics Reports Deeper Than Expected Q4 Loss, Updates Upcoming Pipeline Milestones – Axsome Therapeutics (NASDAQ:AXSM) Read more
Biotechnology UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst – Axsome Therapeutics (NASDAQ:AXSM) Read more
